Cell NetwoRx is Bridging the Gap Between Multi-Target Disease Pathways and Drug Discovery
Cell NetwoRx LLC is focused on the discovery and development of small molecule drugs that act on our proprietary angiogenesis target with therapeutic applications in eye disease, oncology and wound healing.
The drug discovery process is driven by Cell NetwoRx's proprietary cell based assay technology, the Pathway Assay Matrix (PAM™). By integrating disease pathway target identification with PAM™ we enable small molecule lead development in the context of the patient disease state.